Patents by Inventor Adam Wayne Johnson

Adam Wayne Johnson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Quinolinone PDE2 inhibitors
    Patent number: 8680116
    Abstract: The present invention is directed to quinolinone compounds which are useful as therapeutic agents for the treatment of central nervous system disorders associated with phosphodiesterase 2 (PDE2). The present invention also relates to the use of such compounds for treating neurological and psychiatric disorders, such as schizophrenia, psychosis or Huntington's disease, and those associated with striatal hypofunction or basal ganglia dysfunction.
    Type: Grant
    Filed: July 19, 2010
    Date of Patent: March 25, 2014
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: Pablo DeLeon, Melissa Egbertson, Ivory D. Hills, Adam Wayne Johnson, Michelle Machacek
  • Quinolinone PDE2 Inhibitors
    Publication number: 20120115885
    Abstract: The present invention is directed to quinolinone compounds which are useful as therapeutic agents for the treatment of central nervous system disorders associated with phosphodiesterase 2 (PDE2). The present invention also relates to the use of such compounds for treating neurological and psychiatric disorders, such as schizophrenia, psychosis or Huntington's disease, and those associated with striatal hypofunction or basal ganglia dysfunction.
    Type: Application
    Filed: July 19, 2010
    Publication date: May 10, 2012
    Inventors: Pablo De Leon, Melissa Egbertson, Ivory D. Hills, Adam Wayne Johnson, Michelle Machacek